Zobrazeno 1 - 10
of 461
pro vyhledávání: ''
Autor:
Takaji Matsutani, Eiichi Ohtsuka, Yoshitaka Imaizumi, Kenji Ishitsuka, Asahi Ito, Makoto Yoshimitsu, Kentaro Yonekura, Ilseung Choi, Atae Utsunomiya, Kisato Nosaka, Nobuaki Nakano, Shinsuke Iida, Ryuzo Ueda, Michihiro Hidaka, Toshiro Kawakita, Takashi Ishida, Youko Suehiro, Junya Makiyama, Hiro Tatetsu, Hidenori Sasaki, Shigeru Kusumoto, Takeharu Kato, Tatsuro Jo, Masao Ogata
Publikováno v:
British Journal of Haematology. 196:629-638
'Monitoring of immune responses following mogamulizumab-containing treatment in patients with adult T-cell leukaemia-lymphoma (ATL)' (MIMOGA) is a multicentre prospective clinical study (UMIN000008696). In the MIMOGA study, we found that a lower perc
Autor:
Michael Fuchs, Andreas Engert, Stephanie Sasse, Elena Gerhard-Hartmann, Sven Borchmann, Arjan Diepstra, Alberto Zamò, Tabea Steinmüller, Peter Borchmann, Johanna Grund, Johanna Veldman, Wolfram Klapper, Sarah Reinke, Susana Ben-Neriah, Anja Mottok, Helen Goergen, Paul J Bröckelmann, Andreas Rosenwald
Publikováno v:
British Journal of Haematology, 196(1), 116-126. Wiley
High programmed cell death 1 ligand 1 (PD-L1) protein expression and copy number alterations (CNAs) of the corresponding genomic locus 9p24.1 in Hodgkin- and Reed-Sternberg cells (HRSC) have been shown to be associated with favourable response to ant
Publikováno v:
British Journal of Haematology. 196:473-487
The management of older individuals (≥60 years) with primary central nervous system lymphoma remains a clinical challenge. Identification of optimal therapy and delivering adequate dose intensity are two of the major issues in treating elderly pati
Publikováno v:
British Journal of Haematology. 196
Autor:
James B. Bussel, Quentin A. Hill, Michelle Sholzberg, Nichola Cooper, Michael D. Tarantino, Sandra Tong, Leslie Todd, Ralph V. Boccia, Michael Boxer, Waleed Ghanima
Publikováno v:
British Journal of Haematology
Fostamatinib demonstrated efficacy in phase 3 trials of adults with immune thrombocytopenia (ITP). Post hoc analysis compared patients who received fostamatinib as second‐line therapy (after steroids ± immunoglobulins) versus third‐or‐later‐
Autor:
Jesus Feliu, Mercedes Rodríguez-Calvillo, Ricardo García-Muñoz, Pilar Giraldo, Ángel Panizo, Susana Inogés, Jorge M. Núñez-Córdoba, Eva Bandrés, Ascensión López-Díaz de Cerio, Nicolas Martinez-Calle, Marcio Andrade-Campos, Esther Pena, Carlos Panizo, Carlos Grande, María Teresa Olave
Publikováno v:
British Journal of Haematology. 189:1064-1073
Anti-cluster of differentiation 20 (CD20) monoclonal antibodies (mAbs) have shown promise in follicular lymphoma (FL) as post-induction therapy, by enhancing antibody-dependent cellular cytotoxicity (ADCC). However, cytotoxic cells are reduced after
Autor:
Georg Aue, Robert Reger, Phuong Vo, Richard W. Childs, Tatyana Worthy, Sharon Adams, Willy A. Flegel, Brian Wells, Emily C. McDuffee, Xin Tian, Kamille A. West, Reem Shalabi, Enkhtsetseg Purev, Geri Hawks, Lisa Cook
Publikováno v:
Br J Haematol
Heavily transfused patients frequently develop human leukocyte antigen (HLA) allo-immunization resulting in platelet transfusion refractoriness and a high risk for life-threatening thrombocytopenia. Data suggest complement activation leading to the d
Autor:
Tom van Meerten, Lydia Visser, Marcel Nijland, Andor W. J. M. Glaudemans, Arjan Diepstra, Anke van den Berg, Hanneke C. Kluin-Nelemans, Gustaaf W. van Imhoff, Wouter J. Plattel
Publikováno v:
British Journal of Haematology
British Journal of Haematology, 190(1), 40-44. Wiley
British Journal of Haematology, 190(1), 40-44. Wiley
Serum thymus and activation regulated chemokine (TARC) levels reflect classical Hodgkin lymphoma (cHL) disease activity and correspond with treatment response. We compared mid-treatment interim TARC (iTARC) with interim 18 F-fluorodeoxyglucose positr
Autor:
Kloos, Robin, van der Sluis, Inge M, Mastrobattista, Enrico, Hennink, Wim, Pieters, Rob, Verhoef, Jan-Jaap, Afd Pharmaceutics, Pharmaceutics
Publikováno v:
British Journal of Haematology, 189(3), 442. Wiley-Blackwell
British Journal of Haematology, 189(3), 442-451. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 189(3), 442-451. Wiley-Blackwell Publishing Ltd
Polyethylene glycol (PEG) conjugated asparaginase (PEGasparaginase) is essential for treatment of paediatric acute lymphoblastic leukaemia. We developed an assay identifying antibodies against the PEG-moiety, the linker and the drug itself in patient
Autor:
Joshua Bomsztyk, Michael P. Lunn, Rajeev Gupta, Lucia Y. Chen, Evan Vitsaras, Stephen Keddie, Shirley D'Sa
Publikováno v:
British Journal of Haematology. 188:511-515
IgM paraprotein-associated peripheral neuropathy (PN) in patients without overt evidence of lymphoma is a recognised clinical entity of unknown aetiology. Interrogating the bone marrow B-cell or plasma cell clones underlying paraproteinemic neuropath